Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
Dollar change
Percentage change
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y14.71% Shs Outstand Perf Week-1.03%
SponsorBlackrock (iShares) ETF Type Tagsequity Return% 3Y3.86% Total Holdings39 Perf Month-0.35%
Fund Family Bond Type Tagspharmaceutical Return% 5Y8.22% AUM689.40M Perf Quarter-1.19%
IndexDow Jones US Sel Pharmaceuticals Indx Average Maturity Tags- Return% 10Y NAV% Perf Half Y9.01%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year12.56%
Active/Passive Quant Type Tags- Flows% 1M2.98% 52W Range55.36 - 69.56 Perf YTD7.13%
Dividend TTM1.00 (1.52%) ESG Type Tags- Flows% 3M5.68% 52W High-4.82% Beta0.67
Dividend Ex-DateJun 11, 2024 Dividend Type Sector/Theme Flows% YTD1.54% 52W Low19.59% ATR (14)0.71
Expense0.40% Structure Type Region Flows% 1Y RSI (14)52.48 Volatility1.24% 1.00%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.28 Prev Close66.61
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume64.40K Price66.21
SMA200.11% SMA501.53% SMA2004.91% Trades Volume17,929 Change-0.59%
Dec-21-23 01:45PM
Sep-20-22 03:13PM
Feb-11-22 11:21AM
Apr-09-20 01:20PM
Feb-07-20 11:05AM
01:00PM Loading…
Jan-16-20 01:00PM
Jan-15-20 01:32PM
Dec-20-19 08:10AM
Nov-06-19 11:00AM
Oct-16-19 10:05AM
Oct-15-19 06:43PM
Sep-11-19 04:43PM
Aug-27-19 04:11PM
Aug-22-19 11:12AM
Aug-07-19 10:59AM
10:50AM Loading…
Jul-17-19 10:50AM
Jul-14-19 11:00AM
Jun-26-19 11:00AM
Jun-25-19 06:01PM
May-14-19 05:40PM
May-09-19 10:05AM
Apr-18-19 05:00PM
Apr-17-19 10:35AM
Apr-09-19 02:14PM
Mar-13-19 06:30AM
Mar-01-19 08:00AM
Feb-21-19 10:08AM
Feb-14-19 01:43PM
Feb-07-19 11:15AM
Jan-29-19 09:08AM
10:59AM Loading…
Jan-23-19 10:59AM
Jan-07-19 09:27AM
Jan-04-19 10:01AM
Dec-27-18 09:35AM
Dec-14-18 03:32PM
Oct-22-18 03:30PM
Oct-09-18 11:39AM
Sep-06-18 04:56PM
Aug-28-18 06:40PM
Jul-03-18 03:19PM
Jun-08-18 04:01PM
May-11-18 03:42PM
Apr-24-18 06:41AM
Jan-26-18 10:32AM
Jan-18-18 02:28PM
Jan-11-18 09:02AM
Jan-10-18 08:16AM
Nov-13-17 07:00AM
Oct-30-17 12:25PM
Sep-26-17 01:55PM
Sep-22-17 01:14PM
Sep-11-17 09:06AM
Sep-08-17 09:07AM
Sep-01-17 09:06AM
Aug-31-17 03:02PM
Aug-30-17 02:27PM
Aug-29-17 07:40AM
Aug-28-17 10:36AM
Aug-23-17 01:30PM
Aug-22-17 10:36AM
Aug-18-17 02:37PM
Aug-14-17 02:52PM
Aug-11-17 05:35PM
Aug-09-17 11:34AM
Aug-08-17 11:37AM
Aug-07-17 01:30PM
Aug-04-17 02:11PM
Aug-03-17 11:34AM
Jul-31-17 04:24PM
Jul-28-17 02:00PM
Jul-27-17 11:25AM
Jul-26-17 02:38PM
Jul-24-17 10:35AM
Jul-20-17 09:40AM
Jul-19-17 11:55AM
Jul-18-17 12:32PM
Jul-17-17 07:38AM
Jul-14-17 02:10PM
Jul-11-17 01:34PM
iShares U.S. Pharmaceuticals ETF seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.